JENNIFER OTERO: Open Payments
NPI 1881387736 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$748 in 20 payments from 11 companies in 2025. Trend: 2023 $281 · 2024 $233 · 2025 $748
Food & beverage: $682Education: $66
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 2 | $190 |
| Galderma Laboratories, L.P. | 3 | $160 |
| Janssen Biotech, Inc. | 3 | $104 |
| Novartis Pharmaceuticals Corporation | 3 | $84 |
| E.R. Squibb & Sons, L.L.C. | 1 | $47 |
| STRATA Skin Sciences, Inc. | 3 | $43 |
| Kerecis Limited | 1 | $28 |
| GENZYME CORPORATION | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Organogenesis Inc. | 1 | $23 |
Products named: DAXXIFY, NEMLUVIO, TREMFYA, DUPIXENT, Sotyktu, COSENTYX, XTRAC, Kerecis SurgiClose.
Industry payments across NM — which companies pay providers there.
